Log in to save to my catalogue

Uncoupling DNA damage from chromatin damage to detoxify doxorubicin

Uncoupling DNA damage from chromatin damage to detoxify doxorubicin

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7334570

Uncoupling DNA damage from chromatin damage to detoxify doxorubicin

About this item

Full title

Uncoupling DNA damage from chromatin damage to detoxify doxorubicin

Publisher

Washington: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2020-06, Vol.117 (26), p.15182-15192

Language

English

Formats

Publication information

Publisher

Washington: National Academy of Sciences

More information

Scope and Contents

Contents

The anthracycline doxorubicin (Doxo) and its analogs daunorubicin (Daun), epirubicin (Epi), and idarubicin (Ida) have been cornerstones of anticancer therapy for nearly five decades. However, their clinical application is limited by severe side effects, especially dose-dependent irreversible cardiotoxicity. Other detrimental side effects of anthrac...

Alternative Titles

Full title

Uncoupling DNA damage from chromatin damage to detoxify doxorubicin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7334570

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7334570

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1922072117

How to access this item